In this view, we aimed to investigate a central innate immune response pathway, the NLRP3 inflammasome, in lung cancer PBMCs and AMs, in order to gain insight on inflammatory processes related to LC. The gene discussed is NLRP3; the disease is laryngotracheoesophageal cleft.